Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

US Gene-Patent Ruling could mean Better Cancer Genetic Tests for Canadians

While Canada is not directly affected by a U.S. Supreme Court decision this week that says human genes cannot be patented, it will likely result in better and faster genetic … Continue reading

June 21, 2013

Ovarian Cancer Advocates Praise Supreme Court Decision on Gene Patents

Ruling Will Give Women More Options to Learn About Genetic Risk  Calaneet Balas CEO, Ovarian Cancer National Alliance Washington, DC-The Supreme Court ruled today that a company cannot patent naturally … Continue reading

June 21, 2013

HPV Vaccine: Why Aren’t Canadians Buying In?

Show full page Mon, 2013-06-03 By Lyba Spring  In March 2007, the Government of Canada allocated $300 million over three years to carry out a provincially-run school-based program across the … Continue reading

June 21, 2013

Recurrent Epithelial Ovarian Cancer: An Update on Treatment

By Olivia W. Foley, BS1, J. Alejandro Rauh-Hain, MD1, Marcela G. del Carmen, MD, MPH1 | April 15, 2013 Full article: http://www.cancernetwork.com/ovarian-cancer/content/article/10165/2137333 ABSTRACT: An estimated 85% of patients with epithelial … Continue reading

June 21, 2013

What Options? When a BRCA Mutation Is Identified by Genetic Testing

“I would say that, for BRCA1 carriers, the breast cancer risk to age 70 is about 55%. For BRCA2 carriers, the breast cancer risk to age 70 is about 45%. … Continue reading

June 21, 2013

Ovarian Cancer Canada research series

Research holds the key to ovarian cancer prevention, early detection, treatment and ultimately, a cure. Ovarian cancer Canada has launched a series on advances in the field of ovarian cancer research. … Continue reading

June 21, 2013

Avastin and recurrent ovarian cancer

Roche Canada will be applying for approval from Health Canada in the near future for the use of Avastin for women with recurrent ovarian cancer. As a component of the approval … Continue reading

June 21, 2013

Talcum Powder Elevates the Risk of Ovarian Cancer: Study

Talcum powder also known as talc is mainly used by women to remain fresh and active.  The practice of discreetly dabbing talcum powder near the genital area as a hygiene … Continue reading

June 21, 2013

Oral Contraceptives as Primary Prevention

Bottom line: Women who use birth control pills are less likely to develop ovarian cancer later in life, a new analysis of past studies suggests. Researchers reviewed 6,476 citations and … Continue reading

June 10, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada